Asia stocks rise as Covid-19 vaccine progress, Biden transition news boost confidence

9

WASHINGTON – Asian markets advanced on Tuesday (Nov 24) as Covid-19 vaccine progress shored up global sentiment and US President-elect Joe Biden was given the go-ahead to begin his White House transition.

US General Services Administration chief Emily Murphy wrote in a letter to Biden on Monday that he can formally begin the hand-over process.

President Donald Trump tweeted that he had told his team “do what needs to be done with regard to initial ,” an indication he was moving toward a transition after weeks of legal challenges to the election results.

That helped futures for the S&P 500 up 0.6 per cent in early Asian trade while Japan’s Nikkei rallied 2.5 per cent. Australia’s S&P/ASX 200 rose 1.1 per cent while South Korea’s Kospi index advanced 0.7 per cent.

Singapore’s Straits Times Index was up 0.8 per cent at 9.49am local time.

Those gains followed an upbeat Wall Street session that was driven by positive vaccine news.

AstraZeneca said its Covid-19 vaccine, cheaper to make, easier to distribute and faster to scale-up than its rivals, could be as much as 90 per cent effective.

US stocks got an extra boost after reports that Biden plans to nominate former Federal Reserve Chair, Janet Yellen, to become the next Treasury Secretary.

“Traders are still buying into vaccine news clearance, as the end of the pandemic becomes imaginable. Recent US data restored a bit of confidence that the economy is holding up, despite surging Covid-19 infections and a painful lack of fresh fiscal stimulus,” said Kyle Rodda, a market analyst for IG Australia.

“And the news of Yellen’s possible nomination to the role of US Treasury Secretary potentially puts a very Fed-friendly uber-dove at the reins of fiscal policy.”

MSCI’s broadest index of Asia-Pacific shares outside Japan rose 0.27 per cent.

The US dollar index touched its lowest since Sept 1 before edging 0.214 per cent higher with the euro unchanged at US$1.184.

On Wall Street, the Dow Jones Industrial Average rose 1.12 per cent, the S&P 500 gained or 0.56 per cent while the Nasdaq Composite added only 0.22 per cent, underperforming as traders rotated away from big tech names.

Some analysts expect big, short-term risks ahead the US Thanksgiving holiday, although others say unexpected news events at the start of the shorter trading week helped investors focus on the growing positives for markets.

Oil prices added to last week’s gains as traders anticipated the vaccine news would spur a recovery in energy demand.

“Investors are ignoring near-term headwinds, chief among which are surging global COVID infections, and instead looking ahead to next summer,” said PVM analyst Stephen Brennock.

The United States surpassed 255,000 deaths and 12 million infections since the pandemic began, with daily infections at a record near 170,000 and daily deaths around 1,500.

US crude recently fell 0.26 per cent to US$42.95 per barrel and Brent was at US$45.83, up 1.94 per cent on the day.

An index of commodity prices touched its highest since early March.

The yield on the benchmark 10-year notes rose slightly to 0.8701 per cent.

Spot gold was little changed at US$1,835.21 an ounce. US gold futures fell 0.46 per cent to US$1,829.30 an ounce.

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More